As CLR also facilitates adhesion of head, neck and breast cancer cells to the lymphatic endothelium and thus favor tumor invasiveness (156), NDC-mediated inhibition of CLR may directly impact in the invasiveness of cancer cells. The gene discussed is DCLK3; the disease is breast carcinoma.